anthrax News
Most Popular anthrax Story
Elusys wins $143M contract for new anthrax treatment
The Department of Health and Human Services has awarded Elusys Therapeutics a contract worth up to $143 million for the development of a new anthrax therapy dubbed Anthim. The contract, which could... Read more...
Latest Headlines
- December 28, 2009
- September 14, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
